MolMed - YouTube
Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA
Will MolMed soon have its first Cell therapy on the Market?
Molmed, l'Opa giapponese in bilico per golden power - ilGiornale.it
Relazione sulla Remunerazione MolMed S.p.A.
MolMed: Contact Details and Business Profile
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
Overview of the Italian Primary Markets
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not
Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders
Sergio Signore (@signore_sergio) / Twitter
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed now part of AGC Biologics | LinkedIn
Il 2019 è l'anno della svolta per MolMed - MilanoFinanza.it
Will MolMed soon have its first Cell therapy on the Market?
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
COMUNICATO STAMPA
MolMed, viaggio nell'officina dei superfarmaci per le terapie geniche - Il Sole 24 ORE
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases | Journal of Medicinal Chemistry
